GRAIL【GRAL】銘柄情報

GRAIL Inc (GRAL) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

66.55

( - )

買値

63.01

売値

67.86

出来高

128

0.00 日の範囲 0.00

29.95 52 週間の範囲 118.84

時価総額

2.856B

前日終値

66.55

始値

時刻

65.11

最終取引時間

19:32:37

財務取引量

VWAP

平均取引量 (3 か月)

US$ 794,640

発行済株式数

42,916,593

配当利回り

PER

-7.17

1 株当たり利益 (EPS)

-10.3

歳入

156.12M

純利益

-395.33M

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate d... GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California. 詳細を表示

セクター

Healthcare

業界

Medical Diagnostics & Screening

ウェブサイト

grail.com

本社

Menlo Park, United States

設立

2026

GRAIL Inc is listed in the Healthcare sector of the ナスダック市場 with ticker GRAL. The last closing price for GRAIL was US$66.55. Over the last year, GRAIL shares have traded in a share price range of US$ 29.95 to US$ 118.84.

GRAIL currently has 42,916,593 shares in issue. The market capitalisation of GRAIL is US$2.86 billion. GRAIL has a price to earnings ratio (PE ratio) of -7.17.

全体の流れ

ベアリッシュ

ネットプレミアム

-45k

Calls / Puts

0.00%

買い / 売り

100.00%

OTM / ITM

0.00%

Sweeps比率

100.00%

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 3 - Initial statement of beneficial ownership of securities

GRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri® Test Substantially Increased Cancer Detection With Robust Performance and Favorable Safety at 2026 ASCO Annual Meeting

GRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri® Test Substantially...

GRAIL Reports Full Results From NHS-Galleri Trial Demonstrating Substantial Reduction in Stage IV Cancer Diagnoses at 2026 ASCO Annual Meeting

GRAIL Reports Full Results From NHS-Galleri Trial Demonstrating Substantial Reduction in Stage IV Cancer...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-7.46	-10.0797189569	74.01	74.49	54.52	1504351	64.67515876	CS
4	3.66	5.81968516457	62.89	79.4999	54.52	852119	65.06857929	CS
12	23.11	53.1998158379	43.44	79.4999	41.53	789844	55.76635619	CS
26	-38.45	-36.619047619	105	118.84	41.5	1022784	67.59640529	CS
52	26.65	66.7919799499	39.9	118.84	29.95	1068911	62.66823908	CS
156	47.92	257.219538379	18.63	118.84	12.33	1153621	43.16978216	CS
260	47.92	257.219538379	18.63	118.84	12.33	1153621	43.16978216	CS